Although the cardiovascular outcomes trial did not find an association between GLP-1 RAs and thyroid cancers [25], the recent FDA Adverse Event Reporting System (FAERS) database analysis confirmed a higher risk of thyroid cancer [21]. This evidence concerns the gene GCG and thyroid cancer.